Pembrolizumab (rrcHL), powder for I.V. infusion, 50 mg and 100 mg vials, Keytruda® Page last updated: 13 July 2018 Public Summary Document (PSD) August 2017 PBAC Meeting - (PDF 135 KB) Public Summary Document (PSD) August 2017 PBAC Meeting - (Word 42 KB)